Home » Pearl Therapeutics Tops $3 Billion Lung Drug in Head-to-Head Trial
Pearl Therapeutics Tops $3 Billion Lung Drug in Head-to-Head Trial
Pearl Therapeutics bagged a whopping $69 million venture round last month, and now it’s pretty clear why.
Xconomy
Xconomy
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May